Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Korro Bio Inc (KRRO)

Korro Bio Inc (KRRO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 409,193
  • Shares Outstanding, K 8,023
  • Annual Sales, $ 0 K
  • Annual Income, $ -81,170 K
  • 60-Month Beta 2.28
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.59
Trade KRRO with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -2.36
  • Number of Estimates 2
  • High Estimate -2.23
  • Low Estimate -2.49
  • Prior Year -27.50
  • Growth Rate Est. (year over year) +91.42%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.51 +1.47%
on 05/13/24
75.80 -33.72%
on 04/15/24
-24.74 (-33.00%)
since 04/12/24
3-Month
46.29 +8.53%
on 02/28/24
97.91 -48.69%
on 03/27/24
-3.57 (-6.63%)
since 02/13/24
52-Week
9.15 +449.07%
on 10/30/23
97.91 -48.69%
on 03/27/24
+31.68 (+170.62%)
since 05/12/23

Most Recent Stories

More News
These 3 Biotech Stocks More Than Doubled in November. Can They Fly Even Higher in 2024?

These stocks are coming off a banner month, but what about the road ahead?

KRRO : 50.24 (-1.49%)
GYRE : 15.75 (+6.28%)
IXHL : 2.62 (+3.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Korro Bio Inc. is an RNA editing company focused on the discovery and development of a new class of precision genetic medicines for both rare and highly prevalent diseases. Korro Bio Inc., formerly known as Frequency Therapeutics Inc., is based in LEXINGTON, Mass.

See More

Key Turning Points

3rd Resistance Point 52.07
2nd Resistance Point 51.41
1st Resistance Point 50.83
Last Price 50.24
1st Support Level 49.58
2nd Support Level 48.92
3rd Support Level 48.34

See More

52-Week High 97.91
Fibonacci 61.8% 64.00
Fibonacci 50% 53.53
Last Price 50.24
Fibonacci 38.2% 43.06
52-Week Low 9.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar